EUVIMEDEUVIMED entdecken
Open Access

CD4 + T cells impair tumor growth through IL-3 and TNF-dependent vascular damage

Qiaoshi Lian iD, Jia Nie, Jatinder Singh iD, Qiang Chen iD, Jennifer Matta iD, Waipan Chan iD, Mariah Balmaceno-Criss iD, Melanie S Vacchio iD, Weiming Yu iD, Alexander D Clark, Elijah Edmondson iD, Michael C Kelly iD und 2 weitere

Science · 18.06.2026 · 392 (6804)

DOI: 10.1126/science.ads7910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 18.06.2026. Verfasst von Qiaoshi Lian und 13 weiteren Autor:innen. Beteiligte Einrichtung: Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health…. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Neovascularization, Pathologic, Tumor Necrosis Factor-alpha, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Cancer Institute, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Most cancer immunotherapy strategies are focused on direct tumor killing by immune cells, especially T lymphocytes. Clinical and conceptual limitations of these approaches create a need for additional strategies. We identified a tumor stroma–targeting mechanism in which tumor antigen–specific CD4 + T cells inhibit tumor growth through myeloid cell and tumor necrosis factor (TNF)–dependent vascular damage. Multiplex immunofluorescence and single-cell and tissue transcriptomics showed that CD4 + T cells trigger the formation of perivascular myeloid cell clusters containing “classically activated” macrophages that produce TNF in response to T cell–derived interleukin-3. TNF causes intratumoral endothelial damage and blood supply disruption, which are associated with localized tumor cell death. Thus, intratumoral antigen-triggered T cell activation can mediate antitumor effects without direct recognition of living tumor cells, thereby avoiding many of the inhibitory mechanisms that limit anti-tumor immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD4-Positive T-LymphocytesNeovascularization, PathologicTumor Necrosis Factor-alphaNeoplasmsImmunotherapyInterleukin-3AnimalsHumansMiceAntigens, NeoplasmCell Line, TumorLymphocyte ActivationMacrophagesMice, Inbred C57BLMyeloid Cells

Substanzen

Antigens, NeoplasmTumor Necrosis Factor-alphaInterleukin-3

Autor:innen und Institutionen

  • Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Laboratory of Immune Cell Biology and Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Single Cell Analysis Facility, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Molecular Histopathology Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

ORCID-Profile: Qiaoshi Lian, Jatinder Singh, Qiang Chen, Jennifer Matta, Waipan Chan, Mariah Balmaceno-Criss, Melanie S Vacchio, Weiming Yu, Elijah Edmondson, Michael C Kelly, Ronald N Germain, Rémy Bosselut

Förderung

  • Intramural NIH HHS
  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases
  • Frederick National Laboratory for Cancer Research

Zitieren

APA

Lian, Q., Nie, J., Singh, J., Chen, Q., Matta, J., Chan, W., Balmaceno-Criss, M., Vacchio, M. S., Yu, W., Clark, A. D., Edmondson, E., Kelly, M. C., Germain, R. N., & Bosselut, R. (2026). CD4 + T cells impair tumor growth through IL-3 and TNF-dependent vascular damage. Science, 392(6804). https://doi.org/10.1126/science.ads7910

Vancouver

Lian Q, Nie J, Singh J, Chen Q, Matta J, Chan W, et al. CD4 + T cells impair tumor growth through IL-3 and TNF-dependent vascular damage. Science. 2026;392(6804). doi:10.1126/science.ads7910

BibTeX
@article{Lian2026,
  author = {Lian, Qiaoshi and Nie, Jia and Singh, Jatinder and Chen, Qiang and Matta, Jennifer and Chan, Waipan and Balmaceno-Criss, Mariah and Vacchio, Melanie S and Yu, Weiming and Clark, Alexander D and Edmondson, Elijah and Kelly, Michael C and Germain, Ronald N and Bosselut, Rémy},
  title = {CD4 + T cells impair tumor growth through IL-3 and TNF-dependent vascular damage},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6804},
  doi = {10.1126/science.ads7910}
}
Kostenlos starten →